| Literature DB >> 30110067 |
Bruna Emanuelle Sanches Borges1, Elza Baia de Brito1, Hellen Thais Fuzii1, Cláudia Simone Baltazar1, Aline Barreto Sá1, Camile Irene Mota da Silva1, Gleyce de Fátima Silva Santos1, Maria da Conceição Nascimento Pinheiro1.
Abstract
Objective To investigate the relation between oxidative stress markers, human papillomavirus infection and cervical cancer precursor lesions. Methods The study comprised women aged 14 to 60 years living in communities located by Amazon rivers in the state of Pará (Itaituba, Limoeiro do Ajuru and Bragança, 126, 68 and 43 women respectively). Papanicolau smears and polymerase chain reaction tests for human papillomavirus DNA detection were performed. Blood samples were collected to test malondialdehyde, total and oxidized glutathione levels. Results Malondialdehyde, total and oxidized glutathione concentrations did not differ significantly (p>0.05) between women with and without low-grade squamous intraepithelial lesions across communities. Malondialdehyde levels (8.02nmols/mL) were almost five times higher in human papillomavirus-positive compared to human papillomavirus-negative women (1.70nmols/mL) living in Itaituba (statistically significant difference; p<0.05). Malondialdehyde levels did not differ significantly (p>0.05) between human papillomavirus-positive and human papillomavirus-negative women living in remaining communities. Significant (p<0.05) differences in total glutathione levels between human papillomavirus-positive and human papillomavirus-negative women (8.20μg/mL and 1.47μg/mL, respectively) were limited to those living in Bragança. Conclusion Malondialdehyde and total glutathione levels were significantly associated with human papillomavirus infection. However, lack of similar associations with squamous lesions suggest oxidative stress alone does not explain correlations with cervical carcinogenesis. Other factors may therefore be involved.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30110067 PMCID: PMC6080701 DOI: 10.1590/s1679-45082018ao4190
Source DB: PubMed Journal: Einstein (Sao Paulo) ISSN: 1679-4508
Malondialdehyde levels, in women with and without cervical cancer precursor lesions
| Low-grade squamous intraepithelial lesion | Itaituba | p value* | Limoeiro do Ajuru | p value* | Bragança | p value* |
|---|---|---|---|---|---|---|
| median; Q1-Q3 | median; Q1-Q3 | median; Q1-Q3 | ||||
| With lesion | (n=11) | 0.120 | (n=3) | - | (n=4) | 0.116 |
| 4.52; 1.74-7.98 | 0.23; 0.21-0.26 | 1.42; 1.20-1.82 | ||||
| Without lesion | (n=115) | (n=65) | (n=39) | |||
| 1.71; 0.86-5.87 | 0.54; 0.28-1.40 | 2.50; 1.46-3.60 |
* p<0.05 statistically difference (Mann-Whitney test).
Q1: first quartile; Q3: third quartile.
Total glutathione and oxidized glutathione levels, in µg/mL, in women with and without cervical cancer precursor
| Low-grade squamous intraepithelial lesion | Itaituba | p value* | Limoeiro do Ajuru | p value* | Bragança | p value* |
|---|---|---|---|---|---|---|
| median; Q1-Q3 | median; Q1-Q3 | median; Q1-Q3 | ||||
| Total GSH | ||||||
| With lesion | (n=11) | 0.869 | (n=3) | - | (n=4) | 0.403 |
| 2.03; 1.35-2.08 | 5.42; 4.12-5.91 | 2.97; 2.51-3.72 | ||||
| Without lesion | (n=115) | (n=65) | (n=39) | |||
| 1.81; 1.43-2.30 | 3.80; 2.95-6.80 | 1.60; 1.08-4.42 | ||||
| GSSG | ||||||
| With lesion | 1.39; 1.36-2.49 | 0.729 | 2.71; 1.00-4.38 | - | 1.55; 1.30-1.90 | 0.464 |
| Without lesion | 1.53; 1.23-2.21 | 2.20; 1.72-2.92 | 1.30; 0.91-1.76 | |||
* p<0.05 statistically difference (Mann-Whitney test).
Q1: first quartile; Q3: third quartile; Total GSH: total glutathione; GSSG: oxidized glutathione.
Malondialdehyde levels, in human papillomavirus positive and negative women
| HPV | Itaituba | p value* | Limoeiro do Ajuru | p value* | Bragança | p value* |
|---|---|---|---|---|---|---|
| median; Q1-Q3 | median; Q1-Q3 | median; Q1-Q3 | ||||
| HPV positive | (n=17) | 0.003 | (n=8) | 0.313 | (n=5) | 0.161 |
| 8.02; 1.54-8.05 | 0.54; 0.13-0.88 | 3.90; 2.50-4.70 | ||||
| HPV negative | (n=109) | (n=60) | (n=38) | |||
| 1.70; 0.85-4.41 | 0.51; 0.27–1.40 | 2.42; 1.40-3.60 |
* p<0.05 statistically difference (Mann-Whitney test).
Q1: first quartile; Q3: third quartile; HPV: human papillomavirus.
Total glutathione and oxidized glutathione levels, in mg/mL, in human papillomavirus positive and negative women
| Total GSH | Itaituba | p value* | Limoeiro do Ajuru | p value* | Bragança | p value* |
|---|---|---|---|---|---|---|
| median; Q1-Q3 | median; Q1-Q3 | median; Q1-Q3 | ||||
| HPV | ||||||
| Positive | (n=17) | 0.650 | (n=8) | 0.789 | (n=5) | 0.021 |
| 1.95; 1.43-2.32 | 3.80; 3.37-5.52 | 8.20; 3.20-8.60 | ||||
| Negative | (n=109) | (n=60) | (n=38) | |||
| 1.80; 1.43-2.25 | 3.77; 2.83-6.50 | 1.47; 1.04-4.07 | ||||
| GSSG | ||||||
| HPV positive | 1.43; 1.36-1.87 | 0.599 | 4.10; 2.80-6.35 | 0.076 | 1.40; 1.21-1.60 | 0.690 |
| HPV negative | 1.55; 1.29-2.29 | 1.86; 0.99-3.46 | 1.30; 0.85-1.78 | |||
* p<0.05 statistically difference (Mann-Whitney test).
Q1: first quartile; Q3: third quartile; HPV: human papillomavirus; GSH: total glutathione; GSSG: oxidized glutathione.